Drugs / MEBO Wound Ointment
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 22 trials | ||||||
| Phase 2 | NCT01070433 | Sep 2012 → Sep 2013 | ulcer of lower limbs | Skingenix, Inc. | Completed | No outcome recorded |
| Phase 2 | NCT01154374 | Nov 2010 → Oct 2011 | ulcer of lower limbs | Skingenix, Inc. | Completed | No outcome recorded |
| Comparator or background therapy1 trial | ||||||
| Phase 4 | NCT07193849 Comparator | Dec 2023 → Dec 2025 overdue | decubitus ulcer | King Abdullah Medical City | Recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 3 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | MEBO Wound Ointment | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01070433 ↗ |
| Route | Topical | “Topical application twice a day” NCT01070433 ↗ |